By vgreene, 23 April, 2020 Proposed mechanism: reduces inflammatory response; has been effective for cytokine storm caused by other diseases; topoisomerase II inhibitors suppress RNA virus replication in vitro
By vgreene, 23 April, 2020 Incr QT prolongation risk when used w/ HCQ or CQ; monitor ECG; FDA MedWatch (4/24/20): Hydroxychloroquine or Chloroquine for COVID-19: Drug Safety Communication - FDA Cautions Against Use Outside of the Hospital Setting or a Clinical Trial Due to Risk of
By vgreene, 23 April, 2020 Arbidol Monotherapy Is Superior to Lopinavir/Ritonavir in Treating COVID-19; access J Infect article